Cargando…
Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma
BACKGROUND: Bladder transitional cell carcinoma (BTCC) is the fourth most frequent neoplasia in men, clinically characterized by high recurrent rates and poor prognosis. Availability of urinary tumor biomarkers represents a convenient alternative for early detection and disease surveillance because...
Autores principales: | Li, Hongjie, Li, Changying, Wu, Huili, Zhang, Ting, Wang, Jin, Wang, Shixin, Chang, Jiwu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089778/ https://www.ncbi.nlm.nih.gov/pubmed/21496341 http://dx.doi.org/10.1186/1477-5956-9-21 |
Ejemplares similares
-
ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma
por: Li, Changying, et al.
Publicado: (2015) -
Identification of Biomarkers Related to Prognosis of Bladder Transitional Cell Carcinoma
por: Liu, Zhihua, et al.
Publicado: (2021) -
Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma
por: Kumar, Prashant, et al.
Publicado: (2015) -
Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma
por: Wang, Yuhan, et al.
Publicado: (2022) -
Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma
por: Song, Ting, et al.
Publicado: (2021)